Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients (2009)
Oliveira, Adriana Morgan; Maria, Durvanei Augusto; Metzger, Martin Andreas 
; Linardi, Camila; Giorgi, Ricardo Rodrigues; Moura, Fernanda; Martinez, Gracia Aparecida; Bydlowski, Sergio Paulo; Novak, Estela Maria
Fonte: Leukemia Research. Unidades: ICB, HU, FM
Assuntos: MIELOMA MÚLTIPLO (TERAPIA), ADJUVANTES IMUNOLÓGICOS, RECEPTORES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Adriana Morgan et al. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients. Leukemia Research, v. 33, n. 7, p. 970-973, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2008.09.018. Acesso em: 04 nov. 2024.APA
Oliveira, A. M., Maria, D. A., Metzger, M. A., Linardi, C., Giorgi, R. R., Moura, F., et al. (2009). Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients. Leukemia Research, 33( 7), 970-973. doi:10.1016/j.leukres.2008.09.018NLM
Oliveira AM, Maria DA, Metzger MA, Linardi C, Giorgi RR, Moura F, Martinez GA, Bydlowski SP, Novak EM. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients [Internet]. Leukemia Research. 2009 ; 33( 7): 970-973.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.09.018Vancouver
Oliveira AM, Maria DA, Metzger MA, Linardi C, Giorgi RR, Moura F, Martinez GA, Bydlowski SP, Novak EM. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients [Internet]. Leukemia Research. 2009 ; 33( 7): 970-973.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.09.018
